Menu

Impact Events

More
Date Lead Company Event Type Approval Change Approval Likelihood
2/7/23 Roche (RHHBY) Crovalimab for Paroxysmal Nocturnal Hemoglobinuria (PNH) Subscribers Only Subscribers Only Subscribers Only
1/30/23 Vera (VERA) Atacicept for Immunoglobulin A (IgA) Nephropathy (Berger's Disease) Subscribers Only Subscribers Only Subscribers Only
1/30/23 Boehringer Ingelheim Spevigo for Psoriasis Subscribers Only Subscribers Only Subscribers Only
1/27/23 Johnson & Johnson (JNJ) Carvykti for Multiple Myeloma (MM) Subscribers Only Subscribers Only Subscribers Only
1/26/23 AC Immune (ACIU) ACI-24 for Alzheimer's Disease (AD) Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected Date Range Lead Company Drug Expected Catalyst
02/08/23 Subscribers Only Subscribers Only Partnership - Acquisition Completion
02/08/23 Subscribers Only Subscribers Only Partnership - Acquisition Completion
02/08/23 Subscribers Only Subscribers Only Regulatory - PDUFA for sNDA/sBLA
02/09/23 Subscribers Only Subscribers Only Regulatory - FDA Advisory Panel Meeting
02/09/23 Subscribers Only Subscribers Only Trial Data - Top-Line Results
Back to the top Back to the top